← FDA DRUG APPROVALS

FDA ANDA · ANDA086826

ELIXOPHYLLIN SR

Sponsor: FOREST LABS

APPLICATION
ANDA086826
TYPE
ANDA
ORIGINAL APPROVAL
1998-02-06
LATEST ACTION
1998-02-06
ROUTE
ORAL
DOSAGE FORM
CAPSULE, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

ELIXOPHYLLIN SRDiscontinued
THEOPHYLLINE 250MG · CAPSULE, EXTENDED RELEASE · ORAL
ELIXOPHYLLIN SRDiscontinued
THEOPHYLLINE 125MG · CAPSULE, EXTENDED RELEASE · ORAL

Approval history

1998-02-06OriginalAP
1995-01-27Labeling · Supplement 3AP
1993-07-27Labeling · Supplement 5AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →